Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Management of Abemaciclib-Associated Adverse Events in Patients With Hormone Receptor–Positive, Human Epidermal Growth Receptor 2–Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3Oncologist 2020 Sep 21;[EPub Ahead of Print], HS Rugo, J Huober, JA Garcia-Saenz, N Masuda, JH Sohn, VAM Andre, S Barriga, J Cox, M Goetz
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.